midazolam and ticagrelor

midazolam has been researched along with ticagrelor in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dalvie, D; Loi, CM; Smith, DA	1
Andersson, TB; Grimm, SW; Zhou, D	1
Butler, K; Teng, R	1

Trials

1 trial(s) available for midazolam and ticagrelor

Article	Year
The effect of ticagrelor on the metabolism of midazolam in healthy volunteers. Clinical therapeutics, 2013, Volume: 35, Issue:7 Topics: Adenosine; Administration, Oral; Adolescent; Adult; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Injections, Intravenous; Male; Midazolam; Middle Aged; Ticagrelor; Young Adult	2013

Article

Year

The effect of ticagrelor on the metabolism of midazolam in healthy volunteers.

Clinical therapeutics, 2013, Volume: 35, Issue:7

Topics: Adenosine; Administration, Oral; Adolescent; Adult; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Injections, Intravenous; Male; Midazolam; Middle Aged; Ticagrelor; Young Adult

2013

Other Studies

2 other study(ies) available for midazolam and ticagrelor

Article	Year
Which metabolites circulate? Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5 Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations	2013
In vitro evaluation of potential drug-drug interactions with ticagrelor: cytochrome P450 reaction phenotyping, inhibition, induction, and differential kinetics. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:4 Topics: Adenosine; Adjuvants, Anesthesia; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Hepatocytes; Humans; Microsomes, Liver; Midazolam; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor	2011

Article

Year

Which metabolites circulate?

Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5

Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations

2013

In vitro evaluation of potential drug-drug interactions with ticagrelor: cytochrome P450 reaction phenotyping, inhibition, induction, and differential kinetics.

Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:4

Topics: Adenosine; Adjuvants, Anesthesia; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Hepatocytes; Humans; Microsomes, Liver; Midazolam; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor

2011